Precigen PGEN
NASDAQ PGEN
$7.11 -0.03 (-0.49%)
As of: Sep 4, 2026 · 3:59 PM EDT

Precigen (PGEN) Non-Current Deferred Tax Liability (2015 - 2024)

Precigen (PGEN) posted quarterly Non-Current Deferred Tax Liability of $1.3 million for Q4 2024, down 88.39% year-over-year from $10.9 million in Q1 2024, and up 1328.09% quarter-over-quarter from $89000.0 in Q3 2024.

Analysis

Precigen (PGEN) Non-Current Deferred Tax Liability (2015 - 2024) Analysis & Trends

Precigen (PGEN) has reported Non-Current Deferred Tax Liability for 10 consecutive years, with $1.3 million the latest figure, recorded in Q4 2024.

  • In Q4 2024, Non-Current Deferred Tax Liability fell 88.39% year-over-year to $1.3 million; the TTM figure through Dec 2024 stood at $1.3 million (down 88.39% YoY), while the FY2024 annual figure was $1.3 million, down 88.39% from the prior year.
  • Non-Current Deferred Tax Liability rose to $1.3 million in Q4 2024 per PGEN's latest filing, from $89000.0 in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $18.5 million in Q4 2021 and bottomed at $77000.0 in Q2 2024.
  • Historically, Non-Current Deferred Tax Liability has averaged $3.9 million across 5 years, with a median of $2.4 million in 2022.
  • Annual changes were most pronounced in 2023 — Non-Current Deferred Tax Liability jumped 383.69% — and 2024, when it plunged 96.47%.
  • Precigen's Non-Current Deferred Tax Liability stood at $12.6 million in 2020, then jumped by 47.0% to $18.5 million in 2021, then sank by 87.8% to $2.3 million in 2022, then surged by 383.69% to $10.9 million in 2023, then plunged by 88.39% to $1.3 million in 2024.
  • Business Quant data shows PGEN's Non-Current Deferred Tax Liability at $1.3 million in Q4 2024, $89000.0 in Q3 2024, and $77000.0 in Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Precigen 2.53 Bn 2.53 Bn 52.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 1.27 Mn
Sep 30, 2024 89,000.00
Jun 30, 2024 77,000.00
Mar 31, 2024 1.78 Mn
Dec 31, 2023 10.95 Mn
Sep 30, 2023 2.13 Mn
Jun 30, 2023 2.18 Mn
Mar 31, 2023 2.24 Mn
Dec 31, 2022 11.44 Mn
Sep 30, 2022 2.09 Mn
Jun 30, 2022 2.26 Mn
Mar 31, 2022 2.44 Mn
Dec 31, 2021 18.54 Mn
Sep 30, 2021 2.57 Mn
Jun 30, 2021 2.69 Mn
Mar 31, 2021 2.72 Mn
Dec 31, 2020 12.62 Mn
Sep 30, 2020 2.73 Mn
Jun 30, 2020 2.70 Mn
Mar 31, 2020 2.79 Mn